Dilemmas encountered by health practitioners offering nuchal translucency screening: A qualitative case study

Prenatal Diagnosis

Volumn 22, Issue 3, 2002, Pages 216-220

  Williams, Clare ^a   Alderson, Priscilla ^b   Farsides, Bobbie ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Down syndrome; Ethic; First trimester; Nuchal translucency; Screening

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; DOWN SYNDROME; FETUS; FETUS ECHOGRAPHY; HEALTH CARE DELIVERY; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; ULTRASOUND;

ABNORMALITIES; ACCESS TO INFORMATION; ATTITUDE OF HEALTH PERSONNEL; DOWN SYNDROME; ETHICS, MEDICAL; FEMALE; HUMANS; INFORMED CONSENT; NECK; PATIENT RIGHTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 0036126149     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.289     Document Type: Article

References (21)

1. What parents are told after prenatal diagnosis of a sex chromosome abnormality: Interview and questionnaire study
2. Obtaining selective consent to scanning, rather than screening, is possible
3. Better understanding of factors influencing uptake is needed
4. Who's for amniocentesis? The politics of prenatal screening
5. Women are being given incomplete information
6. Perceptions of routine nuchal translucency screening
7. Serum screening for Down's syndrome: Experiences of obstetricians in England and Wales
8. On ambivalence and risk: Reflexive modernity and the new human genetics
9. Counselling should be considered an integral part of screening programmes
10. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome
11. The utilisation of nuchal translucency as a prenatal marker of Down syndrome, 1993-1999
12. The 11-14 week scan
13. Why women say yes to prenatal testing
14. Lack of knowledge in health professionals: A barrier to providing information to patients
15. One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
16. Down's syndrome screening: Where to now?